A carregar...
Cyclic-ketoximes as ER beta-selective agonists
The development of selective ERβ-agonists represents a therapeutic strategy against several kinds of cancers, but the high homology between the two receptor subtypes, ERα and ERβ, makes the achievement of this goal very challenging. In the past, we developed salicylaldoxime- and salicylketoxime-base...
Na minha lista:
| Publicado no: | ChemMedChem |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4993649/ https://ncbi.nlm.nih.gov/pubmed/27135651 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cmdc.201600140 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|